Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system
Int J Clin Pharm. 2024 Jun;46(3):776.
doi: 10.1007/s11096-024-01728-8.
1 Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China.
2 School of Pharmaceutical, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
3 Department of Pharmacy, Women and Children's Hospital, School of Medicine, Xiamen University, 10# Zhenhai Road, Xiamen, China. zhuangwei1333@gmail.com.